Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis.
- 1From the Lymphedema Clinic Tokyo, Tokyo, Japan.
- 2Department of Lymphatic and Reconstructive Surgery, JR Tokyo General Hospital, Tokyo, Japan.
Abstract
Background
Recurrent cellulitis is a disabling complication of lymphedema, causing repeated antibiotic exposure, hospitalization, anxiety, activity restriction, and worsening edema. Although compression, skin care, early treatment, and antibiotic prophylaxis are established, recurrence may persist when lymphatic dysfunction, lymphorrhea, occult entry portals, or local lymphatic lesions remain unaddressed. This narrative review reframes recurrent cellulitis as chronic lymphatic vulnerability and proposes an integrated prevention framework.Methods
English-language literature from April 2000 to March 2026 was reviewed using PubMed/MEDLINE, reference lists, consensus documents, and clinical guidelines. Evidence was synthesized narratively across pathophysiology, conservative care, antibiotic prophylaxis, local disease control, lymphatic imaging, lymphaticovenular anastomosis (LVA), and patient education. No quantitative pooling was performed.Results
Compression therapy reduced recurrent cellulitis from 40% to 15% in chronic leg edema, supporting edema control as infection prevention. Antibiotic prophylaxis can reduce recurrence during active treatment but does not correct lymphatic stasis, skin-barrier failure, lymphorrhea, or persistent portals of entry. LVA reduced cellulitis from 1.46 to 0.18 episodes per year in one clinical study, and randomized evidence supports LVA combined with conservative therapy. Local excision combined with genital or lower-limb LVA reduced cellulitis from 2.8 to 0.31 episodes per year in patients with genital lymphatic vesicles.Conclusions
Durable prevention requires coordinated use of conservative care, antibiotic stabilization, local disease control, lymphatic imaging, selective LVA, and patient education. This multidisciplinary framework may help reduce recurrent febrile cellulitis while supporting safer antibiotic discontinuation, activity, confidence, and quality of life.
Related
- Therapeutic Lymphaticovenular Anastomosis for Breast Cancer-Related Lymphedema: A Critical Narrative Review of Comparative Evidence
- Single-dose versus short-course antibiotic prophylaxis in laparoscopic right hemicolectomy with intracorporeal anastomosis: a retrospective cohort study
- Multiple panniculitis presenting as orbital cellulitis: a rare case report
- Campylobacter fetus Bacteremia Presenting with Bilateral Lower Leg Cellulitis in an Immunocompetent Adult
- Bullous cellulitis with bacteraemia caused by multi-drug resistant Myroides odoratimimus species
BibTeX
@article{mihara2026recurrent,
title = {{Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis.}},
author = {Makoto Mihara and Hisako Hara},
journal = {Plastic and reconstructive surgery. Global open},
year = {2026},
month = oct,
doi = {10.1097/gox.0000000000008209},
url = {https://europepmc.org/article/MED/42948848},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis.
AU - Makoto Mihara
AU - Hisako Hara
PY - 2026
DA - 2026/10/27
JO - Plastic and reconstructive surgery. Global open
DO - 10.1097/gox.0000000000008209
UR - https://europepmc.org/article/MED/42948848
AB - Background Recurrent cellulitis is a disabling complication of lymphedema, causing repeated antibiotic exposure, hospitalization, anxiety, activity restriction, and worsening edema. Although compression, skin care, early treatment, and antibiotic prophylaxis are established, recurrence may persist when lymphatic dysfunction, lymphorrhea, occult entry portals, or local lymphatic lesions remain unaddressed. This narrative review reframes recurrent cellulitis as chronic lymphatic vulnerability and proposes an integrated prevention framework.Methods English-language literature from April 2000 to March 2026 was reviewed using PubMed/MEDLINE, reference lists, consensus documents, and clinical guidelines. Evidence was synthesized narratively across pathophysiology, conservative care, antibiotic prophylaxis, local disease control, lymphatic imaging, lymphaticovenular anastomosis (LVA), and patient education. No quantitative pooling was performed.Results Compression therapy reduced recurrent cellulitis from 40% to 15% in chronic leg edema, supporting edema control as infection prevention. Antibiotic prophylaxis can reduce recurrence during active treatment but does not correct lymphatic stasis, skin-barrier failure, lymphorrhea, or persistent portals of entry. LVA reduced cellulitis from 1.46 to 0.18 episodes per year in one clinical study, and randomized evidence supports LVA combined with conservative therapy. Local excision combined with genital or lower-limb LVA reduced cellulitis from 2.8 to 0.31 episodes per year in patients with genital lymphatic vesicles.Conclusions Durable prevention requires coordinated use of conservative care, antibiotic stabilization, local disease control, lymphatic imaging, selective LVA, and patient education. This multidisciplinary framework may help reduce recurrent febrile cellulitis while supporting safer antibiotic discontinuation, activity, confidence, and quality of life.
SN - 2169-7574
ER -